Expert NetworkExpert InterviewBoehringer Ingelheim

Slingshot members are talking to an expert! The topic is:

Discussing the potential use of schizophrenia prescription digital therapeutics (PDT) with a close look at the CT-155 software from Boehringer Ingelheim and Click Therapeutics.

Executed on:Jun 4, 2024 11:00 AM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: University of Indiana
  • Professor of Psychiatry at the University of Indiana
  • Manages approximately 50 schizophrenia patients each month.
  • Research focus on schizophrenia; author on Emergent trial published in NEJM.

Interview Goal

Reviewing the standard of care for schizophrenia and the future use of prescription digital software as a therapeutic option for patients. A close look at Boehringer and Click's CT-155.

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.